Cargando…

Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality

Recombinant human tumor necrosis factor-alpha (TNF-alpha) has demonstrable antitumor activity in transplantable murine tumor models and patients with cancer but is highly toxic to both animals and human beings. The narrow therapeutic index of TNF-alpha has limited its anticancer utility. Toxicity as...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1994
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191660/ https://www.ncbi.nlm.nih.gov/pubmed/8064225

Ejemplares similares

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice
Publicado: (1988)

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection
Publicado: (1989)

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection
Publicado: (1987)

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation
Publicado: (1990)

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
Publicado: (1988)

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines
Publicado: (1988)

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium
Publicado: (1990)

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia
Publicado: (1989)

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line
Publicado: (1989)

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1
Publicado: (1986)

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential
Publicado: (1986)

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes
Publicado: (1988)

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas
Publicado: (1988)

Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary
Publicado: (1991)

Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses
Publicado: (1988)

Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells
Publicado: (1988)

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1
Publicado: (1986)

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
Publicado: (1989)

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5)
Publicado: (1988)

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway
Publicado: (1990)

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease
Publicado: (1987)

Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins
Publicado: (1989)

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts
Publicado: (1985)

A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells
Publicado: (1990)

Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor
Publicado: (1987)

Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
Publicado: (1994)

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors
Publicado: (1986)

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody
Publicado: (1988)

Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses
Publicado: (1991)

Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin [published erratum appears in J Exp Med 1989 Nov 1;170(5):1793]
Publicado: (1989)

Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2]
Publicado: (1990)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor
Publicado: (1988)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
por: Agarwal, Renu, et al.
Publicado: (2012)

A Mediator Role For Metallothionein in Tumor Necrosis Factor–induced Lethal Shock
por: Waelput, Wim, et al.
Publicado: (2001)

Type I interferon drives tumor necrosis factor–induced lethal shock
por: Huys, Liesbeth, et al.
Publicado: (2009)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_01mvvk9dffdo84tejb15dgvekv